Hostname: page-component-76fb5796d-5g6vh Total loading time: 0 Render date: 2024-04-29T03:46:02.868Z Has data issue: false hasContentIssue false
  • English
  • Français

Are neurotransmitters passé? A view from the foothills in response to Rose

Published online by Cambridge University Press:  27 October 2023

Sameer Jauhar Open the ORCID record for Sameer Jauhar [Opens in a new window]  and
Philip J. Cowen Open the ORCID record for Philip J. Cowen [Opens in a new window]
Sameer Jauhar*
Affiliation:
Department of Psychological Medicine, IoPPN, King's College, London, UK
Philip J. Cowen
Affiliation:
Department of Psychiatry, University of Oxford, Oxford, UK Oxford Health NHS Trust, Oxford, UK
*
Corresponding author: Sameer Jauhar; Email: sameer.jauhar@kcl.ac.uk
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Invited Commentary
Information
Psychological Medicine , Volume 53 , Issue 16 , December 2023 , pp. 7976 - 7977
Copyright
Copyright © The Author(s), 2023. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Goodwin, G. M., Malievskaia, E., Fonzo, G. A., & Nemeroff, C. B. (2023). Must psilocybin always ‘assist psychotherapy?’ American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.20221043Google ScholarPubMed
Healy, D. (1997). The antidepressant era. Cambridge, MA: Harvard University Press.Google Scholar
Jauhar, S., Johnstone, M., & McKenna, P. J. (2022). Schizophrenia. Lancet (London, England), 399(10323), 473–486. https://doi.org/10.1016/S0140-6736(21)01730-XCrossRefGoogle ScholarPubMed
Jauhar, S., Veronese, M., Nour, M. M., Rogdaki, M., Hathway, P., Natesan, S., … Howes, O. D. (2019). The effects of antipsychotic treatment on presynaptic dopamine synthesis capacity in first-episode psychosis: A positron emission tomography study. Biological Psychiatry, 85(1), 79–87. https://doi.org/10.1016/j.biopsych.2018.07.003CrossRefGoogle ScholarPubMed
Jelen, L. A., & Stone, J. M. (2021). Ketamine for depression. International Review of Psychiatry, 33(3), 207–228. https://doi.org/10.1080/09540261.2020.1854194CrossRefGoogle ScholarPubMed
Kapur, S., Zipursky, R., Jones, C., Remington, G., & Houle, S. (2000). Relationship between dopamine D2 occupancy, clinical response, and side effects: A double-blind PET study of first-episode schizophrenia. American Journal of Psychiatry, 157(4), 514–520. https://doi.org/10.1176/appi.ajp.157.4.514CrossRefGoogle ScholarPubMed
Ling, S., Ceban, F., Lui, L. M. W., Lee, Y., Teopiz, K. M., Rodrigues, N. B., … McIntyre, R. S. (2022). Molecular mechanisms of psilocybin and implications for the treatment of depression. CNS Drugs, 36(1), 17–30. https://doi.org/10.1007/s40263-021-00877-yCrossRefGoogle ScholarPubMed
McGilchrist, I. (2017). Depression is not like anything on earth. In Foster, C., & Herring, J. (Eds.), Depression: law and ethics. Oxford: Oxford University Press.Google Scholar
Sigvard, A. K., Nielsen, M. Ø., Gjedde, A., Bojesen, K. B., Fuglø, D., Tangmose, K., … Glenthøj, B. Y. (2022). Dopaminergic activity in antipsychotic-naïve patients assessed with positron emission tomography before and after partial dopamine D2 receptor agonist treatment: Association with psychotic symptoms and treatment response. Biological Psychiatry, 91(2), 236–245. https://doi.org/10.1016/j.biopsych.2021.08.023CrossRefGoogle ScholarPubMed
Smith, K. A., Fairburn, C. G., & Cowen, P. J. (1997). Relapse of depression after rapid depletion of tryptophan. Lancet (London, England), 349(9056), 915–919. https://doi.org/10.1016/s0140-6736(96)07044-4CrossRefGoogle ScholarPubMed